glp-1 prescriptions growth q1 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1s: The Swiss Army Knife

As GLP-1 spending continues to skyrocket, understanding and addressing behavioral and systemic barriers is essential for sustainable market growth

A retrospective analysis of electronic health records by Wilding et al

Pharmaceutical companies have invested billions developing advanced transdermal technologies (iontophoresis, sonophoresis, chemical enhancers, microneedles) specifically because passive patches cannot deliver most drugs

13 You must wait for approval, wait for the inevitable shortage (because demand always exceeds supply), and then move with precision

Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement

Not coffee